StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note released on Friday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance NYSE BTX opened at $1.37 on Friday. The firm has a market capitalization of $80.59 million, a P/E ratio of -1.81 and a […]